Faster, better, together: Biopharma collaboration trends in the pandemic, and the future of medicine

Webinar

On demand

Replay

The strategic collaborations born out of the efforts to help address the COVID-19 pandemic have offered a wealth of insight into how the biopharma industry will continue to change in the years to come. Companies across the supply chain - from raw materials and technology suppliers to biomanufacturers - view collaboration as a critical strategy to advancing biologics research, scale-up and manufacturing for all biologics development.

Watch Avantor´s and C&EN´s webinar featuring Avantor subject matter experts and guest industry speakers, discussing the benefits of partnership and collaboration.

This webinar event, hosted by C&EN, took place October 27, 2021

Presented by:

  Justin Moran, PhD, Executive Director, Head of Early Bioprocess Development, Pfizer Vaccines
The Impact of a Pandemic on Process Development
 
  Nandu Deorkar, PhD, Vice President, R&D - Bioprocessing, Avantor
A collaborative ecosystem to accelerate the commercial manufacturing of novel vaccines and other therapeutics
 
  Jennifer Grossman, PhD, Business Development Manager, Pilot Bioproduction Facility, Walter Reed Army Institute of Research
Lessons on flexibility and scaling-up fast: how the biopharmaceutical industry is preparing to face the next pandemic
 
  Claudia Berrón, MBA, Senior Vice President, Avantor Clinical Services, Avantor
The impact of decentralization and digitization on clinical trial logistics, kits, and sample management
     
  Pranav Vengsarkar, PhD, Manager, Process Development, Research Biopharma Production, Avantor
Enhanced raw material delivery strategies: Debottlenecking of buffer and media preparation in mAbs and novel therapeutics